GSE158552 BRD4 inhibition 2 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE158552_BRD4 inhibition_2_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE158552_BRD4 inhibition_2_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE158552_BRD4 inhibition_2_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE158552_BRD4 inhibition_2_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

differentiation antagonizing non-protein coding RNA

Gene

small nucleolar RNA host gene 16

Gene

small nucleolar RNA host gene 4

Gene

long intergenic non-protein coding RNA 511

Gene

MIR1915 host gene

Gene

H2A clustered histone 4

Gene

HOXD antisense growth-associated long non-coding RNA

Gene

long intergenic non-protein coding RNA 3219

Gene

MIR34A host gene

Gene

small nucleolar RNA host gene 26

  • Gene

    differentiation antagonizing non-protein coding RNA


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    small nucleolar RNA host gene 4


  • Gene

    long intergenic non-protein coding RNA 511



  • Gene

    H2A clustered histone 4


  • Gene

    HOXD antisense growth-associated long non-coding RNA


  • Gene

    long intergenic non-protein coding RNA 3219



  • Gene

    small nucleolar RNA host gene 26

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.